cash flow reconciliationreview2020-12-31
Operating, investing and financing flows differ from the reported change in cash by 12556000, beyond tolerance 5843080.00.
Revenue
$5.08B
Fiscal year ended 2025-12-31Operating income
$750.21M
Fiscal year ended 2025-12-31Free cash flow
$734.65M
Fiscal year ended 2025-12-31Genpact LTD (G) reported revenue of $5.08B and net income of $552.49M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Genpact LTD’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Management Consulting Services.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B | $3.71B | $3.52B | $3.00B | $2.74B | $2.57B |
| Cost of revenue | $3.25B | $3.08B | $2.91B | $2.83B | $2.59B | $2.42B | $2.29B | $1.92B | $1.68B | $1.55B |
| Gross profit | $1.83B | $1.69B | $1.57B | $1.54B | $1.43B | $1.29B | $1.23B | $1.08B | $1.06B | $1.02B |
| Operating income | $750.21M | $702.06M | $630.86M | $502.15M | $509.00M | $438.72M | $429.38M | $348.15M | $331.28M | $341.21M |
| Net income | $552.49M | $513.67M | $631.26M | $353.40M | $369.45M | $308.28M | $304.88M | $282.02M | $263.11M | $269.68M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 176.65M | shares 180.44M | shares 185.14M | shares 188.09M | shares 192.96M | shares 195.78M | shares 195.16M | shares 193.98M | shares 197.05M | shares 210.13M |
| Pretax income | $730.15M | $676.82M | $602.22M | $465.24M | $483.13M | $400.48M | $399.42M | $362.02M | $320.58M | $329.64M |
| Income tax expense | $177.65M | $163.15M | -$29.03M | $111.83M | $113.68M | $92.20M | $94.54M | $80.76M | $59.74M | $62.10M |
| Diluted EPS | $3.13 | $2.85 | $3.41 | $1.88 | $1.91 | $1.57 | $1.56 | $1.45 | $1.34 | $1.28 |
| Selling, general & administrative | $1.05B | $967.14M | $913.06M | $938.38M | $865.72M | $789.85M | $794.90M | $693.86M | $689.46M | $652.97M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $853.84M | $648.25M | $583.67M | $646.76M | $899.46M | $680.44M | $467.10M | $368.40M | $504.47M | $422.62M |
| Total assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B | $4.87B | $4.45B | $3.53B | $3.45B | $2.89B |
| Current assets | $2.66B | $2.08B | $1.89B | $1.78B | $1.92B | $1.75B | $1.55B | $1.36B | $1.43B | $1.23B |
| Total liabilities | $3.29B | $2.60B | $2.56B | $2.76B | $3.08B | $3.04B | $2.77B | $2.13B | $2.02B | $1.59B |
| Current liabilities | $1.60B | $963.74M | $1.32B | $1.10B | $1.31B | $1.20B | $910.21M | $976.31M | $838.78M | $731.36M |
| Total equity incl. NCI | $2.55B | $2.39B | $2.25B | $1.83B | $1.90B | $1.83B | $1.69B | $1.40B | $1.42B | $1.29B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $1.69B | Unavailable | $4.75M | $4.52M |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $1.24B | $1.20B | $1.12B | $994.76M | $887.74M | $881.02M | $914.26M | $774.18M | $693.08M | $615.26M |
| Goodwill | $1.78B | $1.67B | $1.68B | $1.68B | $1.73B | $1.70B | $1.57B | $1.39B | $1.34B | $1.07B |
| Long-term debt | $1.17B | $1.20B | $824.72M | $1.25B | $1.27B | $1.31B | $1.34B | $975.64M | $1.01B | $698.15M |
| Accounts payable | $27.53M | $36.47M | $27.74M | $35.81M | $24.98M | $13.91M | $21.98M | $42.58M | $15.05M | $9.77M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $812.86M | $615.42M | $490.81M | $443.67M | $694.28M | $584.31M | $427.89M | $339.51M | $359.08M | $345.77M |
| Capital expenditures | $78.20M | $82.77M | $55.42M | $50.61M | $53.34M | $70.17M | $74.93M | $84.98M | $57.23M | $81.93M |
| Investing cash flow | -$495.50M | -$105.96M | -$78.94M | -$36.59M | -$122.75M | -$266.40M | -$357.12M | -$276.05M | -$361.99M | -$125.76M |
| Financing cash flow | -$106.82M | -$424.85M | -$483.00M | -$571.40M | -$332.88M | -$92.01M | $39.65M | -$135.19M | $47.19M | -$232.80M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $225.90M | $110.42M | -$71.73M | Unavailable | Unavailable |
| Stock-based compensation | $89.62M | $66.38M | $88.58M | $77.37M | $81.97M | $74.01M | $83.88M | $49.00M | $35.68M | $25.11M |
| Common dividends paid | $117.75M | $108.47M | $100.01M | $91.84M | $80.48M | $74.21M | $64.67M | $57.10M | $46.69M | Unavailable |
| Common share repurchases | Unavailable | $252.67M | $225.50M | $214.08M | $298.22M | $137.11M | $30.02M | $154.16M | $219.78M | $345.20M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $734.65M | $532.66M | $435.39M | $393.06M | $640.94M | $514.14M | $352.96M | $254.53M | $301.85M | $263.85M |
| Gross margin | 36.0% | 35.5% | 35.1% | 35.1% | 35.6% | 34.8% | 34.8% | 36.0% | 38.6% | 39.5% |
| Operating margin | 14.8% | 14.7% | 14.1% | 11.5% | 12.7% | 11.8% | 12.2% | 11.6% | 12.1% | 13.3% |
| FCF margin | 14.5% | 11.2% | 9.7% | 9.0% | 15.9% | 13.9% | 10.0% | 8.5% | 11.0% | 10.3% |
| SBC / revenue | 1.8% | 1.4% | 2.0% | 1.8% | 2.0% | 2.0% | 2.4% | 1.6% | 1.3% | 1.0% |
| Current ratio | 1.66x | 2.16x | 1.44x | 1.61x | 1.47x | 1.45x | 1.70x | 1.39x | 1.71x | 1.68x |
| Revenue YoY growth | 6.6% | 6.5% | 2.4% | 8.7% | 8.4% | 5.4% | 17.3% | 9.6% | 6.5% | Unavailable |
| Net margin | 10.9% | 10.8% | 14.1% | 8.1% | 9.2% | 8.3% | 8.7% | 9.4% | 9.6% | 10.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 1.5% | 1.7% | 1.2% | 1.2% | 1.3% | 1.9% | 2.1% | 2.8% | 2.1% | 3.2% |
| Long-term debt / equity | 0.46x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 24.3% | 24.1% | -4.8% | 24.0% | 23.5% | 23.0% | 23.7% | 22.3% | 18.6% | 18.8% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open G in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-12View SEC filing
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2019-12-31
Difference 1689171000 exceeds tolerance 4454184.000. Presentation or filing-vintage differences need review.
cash flow reconciliationreview2019-12-31
Operating, investing and financing flows differ from the reported change in cash by 11716000, beyond tolerance 4278880.00.
cash flow reconciliationreview2018-12-31
Operating, investing and financing flows differ from the reported change in cash by 64346000, beyond tolerance 3395110.00.